Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Illumina

Founders David R. Walt John Stuelpnagel Larry Bock Satnam Alag

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 21
Average round size
info
The average size of a deal this fund participated in
$80M
Portfolio companies 16
Rounds per year 0.81
Lead investments 4
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.24
Exits 5
Key employees 1
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Biotechnology
  • Health Care
  • Health Diagnostics
  • Genetics
  • Biopharma
Summary

Illumina is the famous Corporate Investor, which was founded in 1998. The company was established in North America in United States. The main office of represented Corporate Investor is situated in the San Diego.

The fund was created by David R. Walt, John Stuelpnagel, Larry Bock, Satnam Alag.

The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Illumina, startups are often financed by IP Group Plc, MVI Finance, HBM Healthcare Investments AG. The meaningful sponsors for the fund in investment in the same round are Sutter Hill Ventures, Yaletown Partners, Warburg Pincus. In the next rounds fund is usually obtained by IP Group Plc, Lansdowne Partners, Invesco.

The top amount of exits for fund were in 2015. This Illumina works on 11 percentage points less the average amount of lead investments comparing to the other organizations. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is generally included in less than 2 deals every year. Considering the real fund results, this Corporate Investor is 7 percentage points more often commits exit comparing to other organizations. The high activity for fund was in 2016.

The fund has no exact preference in some founders of portfolio startups. If startup sums 4 of the founder, the chance for it to be financed is low. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight GRAIL, Oxford Nanopore Technologies, Human Longevity. Among the most popular fund investment industries, there are Wellness, Genetics. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Illumina:
Typical Co-investors
Illumina is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Illumina:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Anjinggao Industry China, Futian, Guangdong
Antheria Holding AG -
Baronsmead Venture Trusts -
Edge Growth Gauteng, Johannesburg, South Africa
FBR CoMotion Venture Capital Seattle, United States, Washington
Ixchel Chicago, Illinois, United States
Jolmo Capital China, Jiangsu, Nanjing
Knife Capital Gauteng, NA - South Africa, South Africa
Krummacher Group Switzerland, Zürich, Zurich
MedPeer Japan, Tokyo
New The Future Beijing, Beijing, China
Sparta Stockholm, Stockholm County, Sweden
Suzhou Jusong China, Jiangsu, Suzhou
Thrive Partners -
TLG Capital England, London, United Kingdom
United States African Development Foundation District of Columbia, United States, Washington
Vito Ventures Bayern, Germany, Munich
Xincheng Investment Beijing, Beijing, China

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Cache

Biopharma
Biotechnology
Information Technology
07 May 2024 Foster City, California, United States

Mantra Bio

Biotechnology
Life Science
$9M04 Jan 2023 San Francisco, California, United States

Neurolytic Healthcare

Medical
Medical Device
Neuroscience
27 Jul 2022 Oxford, Oxfordshire, United Kingdom

ConcR

Health Care
$684K01 Apr 2021 London, England, United Kingdom

Helix

Big Data
Bioinformatics
Biotechnology
Genetics
Health Care
Personal Health
$200M01 Mar 2018 California, United States

Prospect Bio

Bioinformatics
Biotechnology
Neuroscience
$2M15 Nov 2016 California, United States

Vitagene

Data Mining
Dietary Supplements
Health Care
Machine Learning
Personal Health
Personalization
Wellness
$2M17 Feb 2016 San Francisco, California, United States

Grail

Biotechnology
Health Care
Health Diagnostics
Medical
Medical Device
$100M12 Jan 2016 California, United States

Helix

Big Data
Bioinformatics
Biotechnology
Genetics
Health Care
Personal Health
$100M15 Aug 2015 California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Illumina?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 21
Average round size 80M
Rounds per year 0.81
Peak activity year 2016
Lead investments 4
Follow on index 0.24
Exits 5
Group Appearance index 0.90

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Cache

Biopharma
Biotechnology
Information Technology
07 May 2024 Foster City, California, United States

Mantra Bio

Biotechnology
Life Science
$9M04 Jan 2023 San Francisco, California, United States

Neurolytic Healthcare

Medical
Medical Device
Neuroscience
27 Jul 2022 Oxford, Oxfordshire, United Kingdom

ConcR

Health Care
$684K01 Apr 2021 London, England, United Kingdom

Helix

Big Data
Bioinformatics
Biotechnology
Genetics
Health Care
Personal Health
$200M01 Mar 2018 California, United States

Prospect Bio

Bioinformatics
Biotechnology
Neuroscience
$2M15 Nov 2016 California, United States

Vitagene

Data Mining
Dietary Supplements
Health Care
Machine Learning
Personal Health
Personalization
Wellness
$2M17 Feb 2016 San Francisco, California, United States

Grail

Biotechnology
Health Care
Health Diagnostics
Medical
Medical Device
$100M12 Jan 2016 California, United States

Helix

Big Data
Bioinformatics
Biotechnology
Genetics
Health Care
Personal Health
$100M15 Aug 2015 California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: